| Featured Clinical Trial: Targeting Tumor Metabolism in Papillary Kidney Cancers - NCI Cancer Bulletin |
|
|
NCI Cancer Bulletin Phase II Study of Bevacizumab and Erlotinib in Subjects with Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal |